The majority of imaging studies conducted during the course of oncology clinical trials consist of standard clinical examinations—CT scans, bone scans, brain scans, etc. However, in some cases it can be beneficial to make use of more sophisticated imaging assays to assess a drug’s mechanism of action, to find efficacy signals within sparse data, or to address questions related to treatment-specific effects.

This talk will discuss some of these techniques and their applications, including:

Perfusion imaging
Diffusion imaging
Molecular imaging
Multi-modality imaging

This webinar is Part 1 of a series on Imaging in Oncology:

Click here for Part 2: Assessing Imaging Outcomes in Immune Oncology (upcoming on Nov 3/21)

Click here for Part 3: Deep Learning for Image Analysis (upcoming on Nov 8/21)

Keywords:

Speaker

Edward Ashton, PhD, VP, Oncology Imaging, Philips BioTel Research

Ed Ashton serves as the Vice President of Oncology Imaging for Philips BioTel Research. In this role, he has provided technical leadership on more than 200 clinical trials in oncology, neurology, and cardiology over the past twenty years. Dr. Ashton is a frequent speaker at international imaging conferences, and has authored many peer-reviewed publications describing his research. Prior to joining BioTel Research, Dr. Ashton was a lead signal processing engineer at The MITRE Corporation in McLean, VA. Earlier in his career, he spent three years as a research engineer with the Naval Research Laboratory, where he received the Alan Berman Research Publication Award and was nominated for the Edison Award for Applied Science.

Message Presenter

Who Should Attend?

This webinar will benefit medical and non-medical professionals in the biopharmaceutical industry, especially those supporting oncology drug development with roles in:

Clinical Research
Clinical Development
Medical Affairs
Clinical Operations
Project Management
Regulatory Affairs

What You Will Learn

This talk will discuss some of these techniques and their applications, including:

Perfusion imaging
Diffusion imaging
Molecular imaging
Multi-modality imaging

Xtalks Partner

Philips BioTel Research

Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials. Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advanced imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians — who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on our scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.